Christopher Raanes - ViewRay President CEO, Director
| VRAYDelisted Stock | USD 0.01 0.0001 1.11% |
CEO
Mr. Chris A. Raanes has served as our President Chief Executive Officer and Director of the Company since February 2013. Mr. Raanes brings over 15 years of experience in the private and public medical device field. As our President and Chief Executive Officer Mr. Raanes has supported our growth and strategic initiatives including our worldwide commercial expansion of MRIdian. Previously Mr. Raanes was Executive Vice President from July 2011 to November 2012 and Chief Operating Officer and Senior Vice President from September 2002 to July 2011 at Accuray Incorporated a medical device company. He also served as Vice President and General Manager Digital Imaging at PerkinElmer Inc. a healthcare company from December 1999 to March 2002 since 2013.
| Age | 49 |
| Tenure | 11 years |
| Phone | 440 703 3210 |
| Web | https://www.viewray.com |
ViewRay Management Efficiency
The company has return on total asset (ROA) of (0.2529) % which means that it has lost $0.2529 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0891) %, meaning that it created substantial loss on money invested by shareholders. ViewRay's management efficiency ratios could be used to measure how well ViewRay manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 86.4 M in liabilities with Debt to Equity (D/E) ratio of 0.54, which is about average as compared to similar companies. ViewRay has a current ratio of 2.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist ViewRay until it has trouble settling it off, either with new capital or with free cash flow. So, ViewRay's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ViewRay sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ViewRay to invest in growth at high rates of return. When we think about ViewRay's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | CEO Age | ||
| Bradley Mason | Orthofix Medical | 63 | |
| Juan Quiros | Establishment Labs Holdings | 52 | |
| Jennifer Simpson | Delcath Systems | 48 | |
| Joel Becker | Neuropace | 56 | |
| Kevin Hykes | CVRx Inc | 58 | |
| Joseph Woody | Avanos Medical | 58 | |
| Takeo Mukai | Acutus MedicalInc | 43 | |
| Raymond Huggenberger | Inogen Inc | 59 | |
| James Corbett | Alphatec Holdings | 56 | |
| Massimo Calafiore | Orthofix Medical | N/A | |
| Stephen Neve | Bone Biologics Corp | 55 | |
| Nadim Yared | CVRx Inc | 56 | |
| Karen Zaderej | Axogen Inc | 62 | |
| Terry Rich | Alphatec Holdings | 48 | |
| Jeffrey Frelick | Bone Biologics Corp | 58 | |
| Charles Sherwood | Anika Therapeutics | 69 | |
| Kevin Smith | Inogen Inc | 53 | |
Management Performance
| Return On Equity | -1.09 | |||
| Return On Asset | -0.25 |
ViewRay Leadership Team
Elected by the shareholders, the ViewRay's board of directors comprises two types of representatives: ViewRay inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ViewRay. The board's role is to monitor ViewRay's management team and ensure that shareholders' interests are well served. ViewRay's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ViewRay's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert McCormack, Chief Officer | ||
| Zachary Stassen, Chief Officer | ||
| David Chandler, CFO | ||
| James Dempsey, Chief Scientific Officer, Director | ||
| Martin MD, Chief Officer | ||
| JD Ziegler, Chief Officer | ||
| Joshua Bilenker, Independent Director | ||
| Karen Hackstaff, VP Marketing | ||
| David Bonita, Independent Director | ||
| Scott Drake, CEO Pres | ||
| Matt Harrison, Director Relations | ||
| Caley Castelein, Independent Director | ||
| Robert Fuchs, Chief Officer | ||
| Douglas Keare, COO | ||
| Brian Roberts, Director | ||
| Mark Gold, Independent Director | ||
| Aditya Puri, Independent Director | ||
| Michael Brandt, Senior Vice President - Sales | ||
| Christopher Raanes, President CEO, Director | ||
| Chris Raanes, President CEO, Director | ||
| Drew Hill, VP Devel |
ViewRay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ViewRay a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.09 | |||
| Return On Asset | -0.25 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (1.02) % | |||
| Current Valuation | 11.47 M | |||
| Shares Outstanding | 183.4 M | |||
| Shares Owned By Insiders | 17.36 % | |||
| Shares Owned By Institutions | 74.60 % | |||
| Number Of Shares Shorted | 5.47 M | |||
| Price To Earning | (5.47) X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ViewRay in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ViewRay's short interest history, or implied volatility extrapolated from ViewRay options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ViewRay information on this page should be used as a complementary analysis to other ViewRay's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in ViewRay Stock
If you are still planning to invest in ViewRay check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ViewRay's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |